Update on Drugs in Advanced Ovarian Cancer

摘要

DO Ovarian cancer is usually diagnosed at an advanced stage, when the prognosis is poor, because no reliable screening test exists. Despite all of our advances in treatment, the recurrence rate in these patients is approximately 80% to 85%. Although the recurrence rates have been fairly flat over the past 1 or 2 decades, we have seen median overall survival improve from 2 to 3 years to approximately 5 years over that time. This represents a near-doubling of the time patients are alive after diagnosis.